Group Tavistock Group is a privately-held investment company with diverse holdings in real estate, life sciences companies, financial services, oil and gas investments, manufacturing, and consumer goods and retail companies.
P.O. Box 9000
Florida, United States
|2017-01-05||Avidity Biosciences||Series B||$16M||Alethea Capital Management, Alexandria Real Estate Equities, Brace Pharma Capital, EcoR1 Capital, F-Prime Capital, Moore Venture Partners, and Takeda Ventures|
|2016-05-11||G1 Therapeutics||Series C||$47M||AJU IB Investment, Cormorant Asset Management, Cowen Private Investments, Eshelman Ventures, Franklin Templeton Investments, Hatteras Venture Partners, Lumira Capital, Mountain Group Capital, RA Capital Management, and Rock Springs Capital|
|2015-08-24||Syndax Pharmaceuticals||Series C||$80M||Arrowpoint Partners, BioMed Ventures, Cormorant Asset Management, Delos Advisors, Domain Associates, EcoR1 Capital, Fidelity Investments, Forward Ventures, Jennison Associates, MPM Capital, OrbiMed Advisors, and RMI Partners|
|2015-04-07||Nabriva Therapeutics||Series B||$120M||Boxer Capital, EcoR1 Capital, Global Life Science Ventures, HBM Partners, Novartis Venture Funds, OrbiMed Advisors, Phase4 Ventures, Vivo Capital, and Wellcome Trust|
|2014-11-12||Blueprint Medicines||Series C||$50M||Biotechnology Value Fund, Casdin Capital, Cowen Private Investments, F-Prime Capital, Nextech Invest, Partner Fund Management, Perceptive Advisors, RA Capital Management, Redmile Group, Sabby Capital, Third Rock Ventures, and Wellington Management|